# OnCo record nct07005336 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct07005336/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct07005336", "NCT07005336" ;
  schema:name "A Study to Compare Uliledlimab Combined With Sintilimab and Chemotherapy Versus Sintilimab Combined With Chemotherapy in Patients With Previously Untr"@en ;
  schema:description "A phase 2 trial of Uliledlimab, Sintilimab, Pemetrexed in non-small-cell lung cancer and small-cell lung cancer, run by TJ Biopharma Co., Ltd., active and no longer recruiting."@en ;
  schema:url <https://onco.cc/trials/nct07005336/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07005336> ;
  onco:status "active" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "2" ;
  schema:startDate "2025-01-09" ;
  onco:cancers <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/sclc/> ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/>, <https://onco.cc/technologies/monoclonal-antibody/> ;
  onco:drugs <https://onco.cc/drugs/uliledlimab/>, <https://onco.cc/drugs/sintilimab/>, <https://onco.cc/drugs/pemetrexed/>, <https://onco.cc/drugs/gemcitabine/> ;
  onco:companies <https://onco.cc/companies/tj-biopharma/> .